Journal of Medicinal Chemistry · 2014 · 109 citations · 54 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntibacterial AgentsAntibacterial PharmacologyFlavonoid BiosynthesisNatural Product Drug DiscoveryStructure-activity Relationship AnalysisAntibacterial Drug DevelopmentBioactive Compound LibrariesGram-positive Bacterial InfectionsMedicinal Chemistry ApplicationsMinimum Inhibitory Concentration DeterminationNovel Antibacterial AgentsNovel Antibacterial Drug Discovery
On the basis of recently reported abyssinone II and olympicin A, a series of chemically modified flavonoid phytochemicals were synthesized and evaluated against Mycobacterium tuberculosis and a panel of Gram-positive and -negative bacterial pathogens. Some of the synthesized compounds exhibited good antibacterial activities against Gram-positive pathogens including methicillin resistant Staphylococcus aureus with minimum inhibitory concentration as low as 0.39 μg/mL. SAR analysis revealed that the 2-hydrophobic substituent and the 4-hydrogen bond donor/acceptor of the 4-chromanone scaffold together with the hydroxy groups at 5- and 7-positions enhanced antibacterial activities; the 2',4'-dihydroxylated A ring and the lipophilic substituted B ring of chalcone derivatives were pharmacophoric elements for antibacterial activities. Mode of action studies performed on selected compounds revealed that they dissipated the bacterial membrane potential, resulting in the inhibition of macromolecular biosynthesis; further studies showed that selected compounds inhibited DNA topoisomerase IV, suggesting complex mechanisms of actions for compounds in this series.
54
Flavonoid intake and risk of chronic diseases
Paul Knekt, Jorma Kumpulainen, Ritva Järvinen et al. · American Journal of Clinical Nutrition · 2002 · 1.8K citations
Intake of Flavonoids and Lung Cancer
Loı̈c Le Marchand, Suzanne P. Murphy, Jean H. Hankin et al. · JNCI Journal of the National Cancer Institute · 2000 · 546 citations